Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study

Cite this paper

@inproceedings{Xu2016SafetyTP, title={Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study}, author={Hongrong Xu and Lei Sheng and Weili Chen and Fei Yuan and Mengjie Yang and Hui Li and Xuening Li and John D. Choi and Guiyu Zhao and Tianxin Hu and Yongguo Li and Yi Zhang and Li Chen}, booktitle={Drug design, development and therapy}, year={2016} }